A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer

NCT02773524 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
250
Enrollment
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

Australasian Gastro-Intestinal Trials Group

Collaborators